🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-27
Trial ID
NCT03392961
Treatments Being Tested
This study is the first administration of GSK2982772 in humans. The study w...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-06
Trial ID
NCT02302404
Treatments Being Tested
This study is testing CTX001 for certain conditions where the body does not...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-06
Trial ID
NCT07577817
This is a study to evaluate the safety, tolerability and pharmacokinetics o...
Status
Completed
Location
Atlanta Center for Medical Research - Sickle Cell Subjects Only
Start Date
2020-10-26
Trial ID
NCT04586985
The goal of this clinical trial is to evaluate the safety, tolerability, an...
Status
Enrolling By Invitation
Location
The first hospital of Lanzhou University
Start Date
2024-07-05
Trial ID
NCT06782958
This study is designed to assess safety, tolerability, pharmacokinetics (PK...
Status
Completed
Location
Auckland Clinical Studies
Start Date
2020-05-17
Trial ID
NCT04271592
This is a Phase 1b, single-cente, randomized, double-blind, placebo-control...
Status
Not Yet Recruiting
Location
Malaria Research and Training Center
Start Date
2026-08
Trial ID
NCT07758985
This is a first-time-in-human study. The overall purpose of the study is to...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-11-17
Trial ID
NCT00849134
Treatments Being Tested
The goal of this clinical study is to learn more about the study drug, GS-4...
Status
Recruiting
Location
Qps-Mra, Llc.
Start Date
2024-08-28
Trial ID
NCT06562907
Treatments Being Tested
A phase 1, randomized, double-blind, placebo-controlled, single and multipl...
Status
Completed
Location
Zhejiang Hospital
Start Date
2024-02-24
Trial ID
NCT06255834
Treatments Being Tested